Apollo Neuro Side Effects: What the Research Actually Says
Executive Briefing
Bottom Line: No published study we identified reports a structured side-effect analysis for Apollo Neuro, with or without percentages.
Access: Apollo Neuro: WZ Executive Protocol.
A reader considering continuous daily wear reasonably wants to know what the downside risk looks like. We went looking for a published answer and found less than expected.
What We Found
The identified anxiety-focused study of Apollo Neuro (Tsang 2024, an observational analysis in a ketamine-assisted therapy context) reports no adverse-event data in its published abstract — it measures GAD-7 anxiety scores only, not safety outcomes.
A separate Apollo-run survey, explicitly labeled "not IRB approved" on the company's own research page, covers a psychedelic harm-reduction context (n=517) and states participants reported no adverse events. That's a self-report survey in an unrelated use case, not a controlled safety trial of daily anxiety-management wear.
We did not identify any published study measuring skin irritation, wear-related discomfort, or adverse-event rates specifically for continuous Apollo Neuro use.
What's Reasonable to Expect Anyway
As a touch-based vibration device, the plausible physical considerations are mechanical, not pharmacological: skin sensitivity at the ankle or wrist wear site, and comfort with vibration intensity, which the device lets users adjust. These are mechanism-based expectations, not measured clinical findings.
Apollo's own product documentation typically carries standard class II wellness-device disclaimers — caution around certain implanted medical devices and during pregnancy. Consult current product documentation and a physician for individual guidance; this article isn't a substitute for either.
Frequently Asked Questions
No published study of Apollo Neuro we identified includes a structured adverse-event analysis with reported percentages.
A separate, non-IRB-approved survey (n=517, psychedelic harm-reduction context) states participants reported no adverse events, but that is a self-report survey, not a controlled safety trial, and covers a different use context.
As a vibration device, plausible physical considerations include skin sensitivity at the wear site and comfort with the vibration intensity, which the device allows adjusting.
We did not identify a published study measuring skin irritation or wear-related discomfort rates specifically.
Apollo Neuro's own disclaimers (typical of class II wellness devices) generally advise against use with certain implanted medical devices and during pregnancy without consulting a physician.
Consult Apollo's current product documentation and a physician for individual medical guidance; this is not medical advice.
Editorial Integrity
Apollo Neuro is a Westchester Zen affiliate partner, disclosed per FTC guidelines. We report what the available published research does and doesn't cover rather than filling gaps with assumption.
Full policy at disclosures.